(Q39945997)

15 September 2017

title

Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer (English)

1 reference

15 September 2017

0 references

cervix uterine cancer

1 reference

Amy L Jonson

1

1 reference

15 September 2017

Lisa M Rogers

series ordinal

2

1 reference

15 September 2017

Sundaram Ramakrishnan

series ordinal

3

1 reference

15 September 2017

Levi S Downs

series ordinal

4

1 reference

15 September 2017

language of work or name

English

0 references

publication date

27 August 2008

1 reference

15 September 2017

1 reference

15 September 2017

volume

111

1 reference

15 September 2017

issue

2

1 reference

15 September 2017

page(s)

356-364

1 reference

The epidemiology of cervical cancer

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.033

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.033

The human papillomavirus E6 protein and its contribution to malignant progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.033

Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.033

Angiogenesis Modulators Expression in Culture Cell Lines Positives for HPV-16 Oncoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.033

Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.033

Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.033

siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.033

RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.033

Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.033

In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by e6 siRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.033

The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.033

Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.033

Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.033

A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.033

RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.033

Sequence- and target-independent angiogenesis suppression by siRNA via TLR3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.033

Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.033

Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.033

Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.033

RNA interference: from gene silencing to gene-specific therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.033

Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.033

Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.033

Activation of the interferon system by short-interfering RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.033

10.1016/J.YGYNO.2008.06.033

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference